<?xml version="1.0" encoding="UTF-8"?>
<p>A highly efficient live-attenuated virus vaccine is available to prevent measles outbreaks. MeV transmissibility is very high and 95% of the population needs to possess anti-measles immunity for disease eradication [
 <xref rid="B43-viruses-11-01017" ref-type="bibr">43</xref>]. In 1997, during a meeting co-sponsored by the World Health Organization (WHO), the Pan American Health Organization (PAHO), and the Centers for Disease Control (CDC), the experts agreed that measles eradication was technically feasible by 2005â€“2010. Nevertheless, vaccination coverage decreased and led to a re-emergence of measles infection. Nowadays, measles global eradication is one of the top priorities of the expanded program on immunization (EPI) supported by the WHO. The Global Vaccine Action Plan aims to eliminate measles in five WHO Regions by 2020. Based on confirmed cases reported by the WHO, the countries with the most measles cases in 2018 were India, Ukraine, Philippines, Brazil, and Yemen. Recently, measles strongly re-emerged in industrialized countries due to the significant decrease in vaccination coverage [
 <xref rid="B4-viruses-11-01017" ref-type="bibr">4</xref>,
 <xref rid="B44-viruses-11-01017" ref-type="bibr">44</xref>].
</p>
